Brendan Ffrench

630 total citations
10 papers, 284 citations indexed

About

Brendan Ffrench is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Brendan Ffrench has authored 10 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Brendan Ffrench's work include Cancer Cells and Metastasis (6 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer-related molecular mechanisms research (3 papers). Brendan Ffrench is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer-related molecular mechanisms research (3 papers). Brendan Ffrench collaborates with scholars based in Ireland, Australia and United Kingdom. Brendan Ffrench's co-authors include Michael Gallagher, John O’Leary, Claudia Gasch, Sinéad Cuffe, Niamh Leonard, Stephen P. Finn, Siobhan Nicholson, Ronan Ryan, Martin P. Barr and Lauren MacDonagh and has published in prestigious journals such as Chemical Communications, Molecular Cancer and Journal of Clinical Pathology.

In The Last Decade

Brendan Ffrench

10 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brendan Ffrench Ireland	9	176	141	110	30	21	10	284
Kiyoung Eun South Korea	8	258 1.5×	181 1.3×	122 1.1×	32 1.1×	20 1.0×	16	395
Berthold Gierke Germany	8	148 0.8×	105 0.7×	72 0.7×	32 1.1×	10 0.5×	12	277
Jieran Li Canada	5	246 1.4×	184 1.3×	104 0.9×	35 1.2×	17 0.8×	9	420
Hwajin Son South Korea	3	187 1.1×	116 0.8×	82 0.7×	27 0.9×	12 0.6×	4	290
Е. В. Кайгородова Russia	11	122 0.7×	189 1.3×	87 0.8×	45 1.5×	17 0.8×	41	333
Samaneh Adelian Iran	10	202 1.1×	84 0.6×	126 1.1×	48 1.6×	23 1.1×	13	310
Chinnadurai Mani United States	14	363 2.1×	225 1.6×	80 0.7×	45 1.5×	20 1.0×	31	474
Jude Alsarraj United States	6	356 2.0×	141 1.0×	115 1.0×	41 1.4×	11 0.5×	6	469
Heidi M. Haikala Finland	7	212 1.2×	131 0.9×	64 0.6×	36 1.2×	29 1.4×	15	309
Patrícia Izetti Brazil	6	217 1.2×	140 1.0×	148 1.3×	39 1.3×	8 0.4×	6	364

Countries citing papers authored by Brendan Ffrench

Since Specialization

Citations

This map shows the geographic impact of Brendan Ffrench's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan Ffrench with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan Ffrench more than expected).

Fields of papers citing papers by Brendan Ffrench

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendan Ffrench. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan Ffrench. The network helps show where Brendan Ffrench may publish in the future.

Co-authorship network of co-authors of Brendan Ffrench

This figure shows the co-authorship network connecting the top 25 collaborators of Brendan Ffrench. A scholar is included among the top collaborators of Brendan Ffrench based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan Ffrench. Brendan Ffrench is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

MacDonagh, Lauren, Michael Gallagher, Brendan Ffrench, et al.. (2021). MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer. Translational Lung Cancer Research. 10(4). 1773–1791. 11 indexed citations

O’Toole, Sharon, Cathy Spillane, Yanmei Huang, et al.. (2020). Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 181(3). 571–580. 8 indexed citations

Monopoli, Marco P., Andrea Zendrini, Dan Wu, et al.. (2018). Endogenous exosome labelling with an amphiphilic NIR-fluorescent probe. Chemical Communications. 54(52). 7219–7222. 20 indexed citations

Gasch, Claudia, Brendan Ffrench, John O’Leary, & Michael Gallagher. (2017). Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention. Molecular Cancer. 16(1). 43–43. 71 indexed citations

Ffrench, Brendan, Claudia Gasch, Karsten Hokamp, et al.. (2017). CD10−/ALDH− cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy. Cell Death and Disease. 8(10). e3128–e3128. 14 indexed citations

MacDonagh, Lauren, Michael Gallagher, Brendan Ffrench, et al.. (2017). Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC. Oncotarget. 8(42). 72544–72563. 65 indexed citations

Lynam‐Lennon, Niamh, Susan Heavey, B. Bibby, et al.. (2016). MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype. Oncotarget. 8(7). 11400–11413. 36 indexed citations

Gallagher, Michael, Cathy Spillane, Brendan Ffrench, et al.. (2015). Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones. Journal of Clinical Pathology. 68(9). 692–702. 4 indexed citations

Ffrench, Brendan, Claudia Gasch, John O’Leary, & Michael Gallagher. (2014). Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention. Molecular Cancer. 13(1). 262–262. 45 indexed citations

10.

Gallagher, Michael, Cynthia Heffron, Alexandros Laios, et al.. (2012). Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples. Journal of Ovarian Research. 5(1). 2–2. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact